Elutia (ELUT) Total Non-Current Liabilities (2019 - 2026)
Elutia recorded quarterly Total Non-Current Liabilities of $30.8 million in Q1 2026, down 2.36% quarter-over-quarter from $31.6 million in Q4 2025, and down 56.62% year-over-year from $71.0 million in Q1 2025.
Elutia's Total Non-Current Liabilities history runs 8 years deep, the most recent figure standing at $30.8 million for Q1 2026.
- In Q1 2026, Total Non-Current Liabilities fell 56.62% year-over-year to $30.8 million; the TTM figure through Mar 2026 stood at $30.8 million (down 56.62% YoY), while the FY2025 annual figure was $31.6 million, down 52.42% from the prior year.
- Total Non-Current Liabilities came in at $30.8 million for Q1 2026 at Elutia, down from $31.6 million in the prior quarter.
- In the past five years, Total Non-Current Liabilities ranged from a high of $104.7 million in Q2 2024 to a low of $30.8 million in Q1 2026.
- A 5-year average of $66.1 million and a median of $70.1 million in 2024 frame the typical range for Total Non-Current Liabilities.
- Across the five-year window, Total Non-Current Liabilities jumped 101.78% in 2022 and tumbled 56.62% in 2026, its largest moves.
- Elutia's Total Non-Current Liabilities stood at $73.7 million in 2022, then climbed by 9.75% to $80.9 million in 2023, then slipped by 18.07% to $66.3 million in 2024, then plunged by 52.42% to $31.6 million in 2025, then slipped by 2.36% to $30.8 million in 2026.
- According to Business Quant data, Total Non-Current Liabilities over the past three periods registered $30.8 million, $31.6 million, and $69.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 20.94 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 40.52 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.78 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 2.44 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 9.85 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 3.53 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 24.21 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 3.47 Bn |
| 10 | Elutia | 45.79 Mn | 17.31 Mn | 1.80 Mn | 30.81 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.81 Mn |
| Dec 31, 2025 | 31.55 Mn |
| Sep 30, 2025 | 69.42 Mn |
| Jun 30, 2025 | 66.73 Mn |
| Mar 31, 2025 | 63.67 Mn |
| Dec 31, 2024 | 76.90 Mn |
| Sep 30, 2024 | 82.40 Mn |
| Jun 30, 2024 | 104.67 Mn |
| Mar 31, 2024 | 84.97 Mn |
| Dec 31, 2023 | 69.27 Mn |
| Sep 30, 2023 | 78.58 Mn |
| Jun 30, 2023 | 74.11 Mn |
| Mar 31, 2023 | 67.06 Mn |
| Dec 31, 2022 | 73.75 Mn |
| Sep 30, 2022 | 71.62 Mn |
| Jun 30, 2022 | 42.75 Mn |
| Mar 31, 2022 | 36.85 Mn |
| Dec 31, 2021 | 52.95 Mn |
| Sep 30, 2021 | 35.49 Mn |
| Jun 30, 2021 | 38.15 Mn |
| Mar 31, 2021 | 41.13 Mn |
| Dec 31, 2020 | 45.35 Mn |
| Sep 30, 2020 | 63.98 Mn |
| Dec 31, 2019 | 38.84 Mn |